PRICES include / exclude VAT
Homepage>BS Standards>29 ELECTRICAL ENGINEERING>29.140 Lamps and related equipment>29.140.01 Lamps in general>PD IEC/TR 62471-3:2015 Photobiological safety of lamps and lamp systems Guidelines for the safe use of intense pulsed light source equipment on humans
Sponsored link
immediate downloadReleased: 2015-01-20
PD IEC/TR 62471-3:2015 Photobiological safety of lamps and lamp systems Guidelines for the safe use of intense pulsed light source equipment on humans

PD IEC/TR 62471-3:2015

Photobiological safety of lamps and lamp systems Guidelines for the safe use of intense pulsed light source equipment on humans

Format
Availability
Price and currency
English Secure PDF
Immediate download
312.18 EUR
You can read the standard for 1 hour. More information in the category: E-reading
Reading the standard
for 1 hour
31.22 EUR
You can read the standard for 24 hours. More information in the category: E-reading
Reading the standard
for 24 hours
93.65 EUR
English Hardcopy
In stock
312.18 EUR
Standard number:PD IEC/TR 62471-3:2015
Pages:34
Released:2015-01-20
ISBN:978 0 580 84356 3
Status:Standard
DESCRIPTION

PD IEC/TR 62471-3:2015


This standard PD IEC/TR 62471-3:2015 Photobiological safety of lamps and lamp systems is classified in these ICS categories:
  • 31.260 Optoelectronics. Laser equipment
  • 29.140.01 Lamps in general

This part of IEC 62471, which is a technical report, provides guidelines for the safe use of INTENSE PULSED LIGHT (IPL) source equipment in professional premises.

This technical report sets out the control measures recommended for the safety of recipients of IPL treatment, staff, service, maintenance personnel and others. Engineering controls which form part of the IPL equipment or the installation are also briefly described to provide an understanding of the general principles of protection.

1.2 Object

The object of this report is to provide information which helps to protect persons from hazardous exposure to optical radiation and other associated hazards by providing guidance on how to establish safety measures and procedures.

NOTE Although the manufacturers provide treatment information in their instructions for use, such information may not be exhaustive or applicable to all CLIENT treatment conditions.

If IPLs are applied to patients in medical premises, the physician is deemed to be responsible for all medical aspects of the treatment including his or her decisions about questions of indication and contraindication such as found in Clauses 5 and 6.